iifl-logo

Glenmark Life Sciences Ltd AGM

944.2
(2.65%)
Oct 9, 2025|12:00:00 AM

Glenmark Life CORPORATE ACTIONS

09/10/2024calendar-icon
09/10/2025calendar-icon
PurposeAGM DateAnnouncement Date
AGM8 Sep 202511 Aug 2025
AGM 08/09/2025 Intimation of 14th Annual general Meeting and Record date Notice of 14th Annual General Meeting Proceedings of the 14th Annual General Meeting (AGM) of Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) held on 08th September, 2025 Please find attached herewith Scrutinizers Report. (As per BSE Announcement Dated on 08/09/2025)

Glenmark Life: Related News

Glenmark Set to Enter $421 Million US ADHD Drug Market

The drug consists of a combination of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate.

17 Apr 2025|03:29 PM
Read More
Glenmark Life Sciences’ Q2 net profit falls 20% y-o-y

The Mumbai-based company's income from operations decreased by roughly 15% to ₹507 Crore in the three months ended September 30.

25 Oct 2024|12:27 PM
Read More
Top stocks for today - 25th October 2024

Here are some of the stocks that may see significant price movement today: ITC, Kansai Nerolac, Coromandel International, etc.

25 Oct 2024|08:14 AM
Read More
Glenmark Pharmaceuticals divests stake in Glenmark Life after Nirma Acquisition

The sale will be conducted through the stock exchange mechanism, adhering to applicable legal requirements.

11 Jul 2024|01:16 PM
Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.